ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
Clinical trial NCT05580562 · RECRUITING
Trial details
- NCT number
- NCT05580562
- Sponsor
- Jazz Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-23
- Primary completion
- 2028-06-01
- Enrollment
- 510
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.